These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15209436

  • 1. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.
    Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S.
    Clin Lab; 2004; 50(5-6):279-89. PubMed ID: 15209436
    [Abstract] [Full Text] [Related]

  • 2. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 3. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, Body JJ, Garnero P.
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [Abstract] [Full Text] [Related]

  • 4. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 5. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
    Cloos PA, Fledelius C.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
    [Abstract] [Full Text] [Related]

  • 6. Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion.
    Leeming DJ, Delling G, Koizumi M, Henriksen K, Karsdal MA, Li B, Qvist P, Tankó LB, Byrjalsen I.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 01; 15(7):1392-5. PubMed ID: 16835341
    [Abstract] [Full Text] [Related]

  • 7. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P, Schott AM, Prockop D, Chevrel G.
    Bone; 2009 Mar 01; 44(3):461-6. PubMed ID: 19071236
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.
    Cloos PA, Christgau S, Lyubimova N, Body JJ, Qvist P, Christiansen C.
    Breast Cancer Res; 2003 Mar 01; 5(4):R103-9. PubMed ID: 12818000
    [Abstract] [Full Text] [Related]

  • 9. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 Mar 01; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 10. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K, Takahashi M, Hoshino H, Kushida K.
    Clin Chim Acta; 2002 Feb 01; 316(1-2):109-15. PubMed ID: 11750280
    [Abstract] [Full Text] [Related]

  • 11. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.
    Kanakis I, Nikolaou M, Pectasides D, Kiamouris C, Karamanos NK.
    J Pharm Biomed Anal; 2004 Mar 01; 34(4):827-32. PubMed ID: 15019061
    [Abstract] [Full Text] [Related]

  • 12. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug 01; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 13. Markers of bone turnover for the management of patients with bone metastases from prostate cancer.
    Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD.
    Br J Cancer; 2000 Feb 01; 82(4):858-64. PubMed ID: 10732759
    [Abstract] [Full Text] [Related]

  • 14. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep 01; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 15. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
    Voorzanger-Rousselot N, Journe F, Doriath V, Body JJ, Garnero P.
    Calcif Tissue Int; 2009 May 01; 84(5):348-54. PubMed ID: 19252761
    [Abstract] [Full Text] [Related]

  • 16. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr 01; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 17. Urinary markers of type I collagen degradation in the dog.
    Allen MJ, Allen LC, Hoffmann WE, Richardson DC, Breur GJ.
    Res Vet Sci; 2000 Oct 01; 69(2):123-7. PubMed ID: 11020362
    [Abstract] [Full Text] [Related]

  • 18. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep 01; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 19. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
    Garnero P, Delmas PD.
    Bone; 2003 Jan 01; 32(1):20-6. PubMed ID: 12584032
    [Abstract] [Full Text] [Related]

  • 20. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H.
    Clin Lab; 2003 Jan 01; 49(5-6):203-7. PubMed ID: 15285175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.